A new Medicaid payment model will change what states pay for brand-name prescription drugs, but it will not change what most enrollees pay at the pharmacy counter.

On October 2, 2026, the Centers for Medicare & Medicaid Services (“CMS”) finalized the Global Benchmark for Efficient Drug Pricing (“GLOBE”) Model, ...

On September 30, 2026, the Centers for Medicare and Medicaid Services (CMS) published a final rule establishing the Global Benchmark for ...

HHS finalized the GLOBE drug pricing model for Medicare Part B, cutting projected savings and narrowing scope as MFN waivers ...

CMS finalizes drug pricing model tying Medicare Part B rebates to prices in 19 countries, effective Nov. 30, 2026, aiming to reduce U.S. drug costs.

Medicare's bundled payment model for joint replacements cut costs by $180 million in its final three years without ...

SAN FRANCISCO, July 31, 2026 /PRNewswire/ -- Today, the Centers for Medicare & Medicaid Services (CMS) issued the fiscal year 2027 Inpatient Prospective Payment System (IPPS) final rule. Within this 1 ...

Blue Shield of California is one of 17 major health plans that has committed to adopting payment models inspired by the Medicare Innovation Center’s ACCESS Model.

The Centers for Medicare and Medicaid Services will expand the Comprehensive Care for Joint Replacement model to most hospitals by 2028, according to a final rule released this afternoon. The rule ...

Medicaid managed care provides a structural framework to fight waste and fraud and reduce the cost to taxpayers.